Pfizer reorganizes to handle aging consumers and patents

Credit: Seattle Times- Published on July 11, 2018
NEW YORK (AP) — Pfizer, facing an aging population and shifting risks from the loss of patents, is reshaping the company into three businesses. The three divisions, announced Wednesday, include Innovative Medicines, which will focus on biological science and other technologies needed to address an aging population. The...
Advertisement

You might like